Patents by Inventor Prem Premsrirut

Prem Premsrirut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of genetic mediated engineering of RNAi models
    Patent number: 11957114
    Abstract: Provided herein are systems and methods for Inducible and conditional CRISPR/Cas9 and RNAi. From animal model creation and the efficiency of CRISPR-based targeting, the present invention comprises developing RNAi models that enable inducible and reversible gene silencing to simulate new therapeutic regimes.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: April 16, 2024
    Assignee: Mirimus, Inc.
    Inventor: Prem Premsrirut
  • REDEFINING LIVESTOCK MILK BY REMOVING FOLATE RECEPTOR PROTEIN TO DECREASE FOLATE RECEPTOR AUTOIMMUNE DISORDER IN PREGNANCY AND AUTISM
    Publication number: 20230172222
    Abstract: Provided herein are systems and methods in Redefining Cow Milk to decrease the prevalence of folate receptor autoimmune disorder in the population to reduce the Incidence of neural tube defect pregnancy, pre-term birth, subfertility and a plethora of developmental disorders including autism spectrum disorders.
    Type: Application
    Filed: July 22, 2022
    Publication date: June 8, 2023
    Inventors: Prem Premsrirut, Edward V. Quadros
  • METHODS OF GENETIC MEDIATED ENGINEERING OF RNAi MODELS
    Publication number: 20210259218
    Abstract: Provided herein are systems and methods for Inducible and conditional CRISPR/Cas9 and RNAi. From animal model creation and the efficiency of CRISPR-based targeting, the present invention comprises developing RNAi models that enable inducible and reversible gene silencing to simulate new therapeutic regimes.
    Type: Application
    Filed: November 28, 2018
    Publication date: August 26, 2021
    Applicant: Mirimus, Inc.
    Inventor: Prem PREMSRIRUT
  • Cell-based RNA interference and related methods and compositions
    Publication number: 20090217404
    Abstract: The invention provides, among other things, methods for performing RNA interference (RNAi) in stem cells (such as embryonic stem cells) and methods for using such stem cells in vivo. The invention also provides various animal models based on conditional/inducible, reversible, tissue-specific/spacial, and/or developmental stage-specific/temporal RNAi of certain target genes, which animal model may be useful for, e.g., drug target identification and/or validation.
    Type: Application
    Filed: February 23, 2008
    Publication date: August 27, 2009
    Inventors: Scott W. Lowe, Michelle A. Carmell, Gregory J. Hannon, Patrick Paddison, Jack Zilfou, Jordan Fridman, Ross Dickins, Michael Hemann, Thomas A. Rosenquist, Prem Premsrirut